Authors: Thomas A. Wadden, PhD; Timothy S. Bailey, MD; Liana K. Billings, MD, MMSc; et al
This study examines the effects of subcutaneous semaglutide on persons while simultaneously being treated with diet and behavioral therapy.
Please note: This article was published by JAMA and is not affiliated with Employer-Provider Interface Council (EPIC). The below link is provided as a suggested reading we believe valuable to EPIC users.
Read the full article https://jamanetwork.com/journals/jama/article-abstract/2777025?guestAccessKey=d67cbeaa-d56b-45c4-b62b-cf5df96ee81e&utm_content=weekly_highlights&utm_term=042521&utm_source=silverchair&utm_campaign=jama_network&cmp=1&utm_medium=email
Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA. 2021;325(14):1403–1413. doi:10.1001/jama.2021.183